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We have previously established a protocol for the neural differentiation of mouse embryonic
stem cells (mESCs) as an efficient tool to evaluate the neurodevelopmental toxicity of envi-
ronmental chemicals. Here, we described a multivariate bioinformatic approach to identify
the stage-specific gene sets associated with neural differentiation of mESCs. We exposed
mESCs (B6G-2 cells) to 10−8 or 10−7 M of retinoic acid (RA) for 4 days during embryoid
body formation and then performed morphological analysis on day of differentiation (DoD)
8 and 36, or genomic microarray analysis on DoD 0, 2, 8, and 36. Three gene sets, namely
a literature-based gene set (set 1), an analysis-based gene set (set 2) using self-organizing
map and principal component analysis, and an enrichment gene set (set 3), were selected
by the combined use of knowledge from literatures and gene information selected from
the microarray data. A gene network analysis for each gene set was then performed using
Bayesian statistics to identify stage-specific gene expression signatures in response to
RA during mESC neural differentiation. Our results showed that RA significantly increased
the size of neurosphere, neuronal cells, and glial cells on DoD 36. In addition, the gene
network analysis showed that glial fibrillary acidic protein, a neural marker, remarkably up-
regulates the other genes in gene set 1 and 3, and Gbx2, a neural development marker,
significantly up-regulates the other genes in gene set 2 on DoD 36 in the presence of RA.
These findings suggest that our protocol for identification of developmental stage-specific
gene expression and interaction is a useful method for the screening of environmental
chemical toxicity during neurodevelopmental periods.
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INTRODUCTION
Humans are exposed to environmental chemicals on a daily basis;
however, many effects of these chemicals on human health are
unclear. Currently, assessment of developmental toxicity on chil-
dren’s health is a large and rapidly growing research field. Children
are not “little adults” and have special vulnerabilities to the toxic
effects of environmental chemicals. For example, brain devel-
opment during embryonic stages is an important period when
microstructures are formed and axon guidance and synapse for-
mation are induced by neuronal signaling (Lamoury et al., 2006;
Ligon et al., 2006). These processes are regulated by stage-specific
gene expression during embryonic development. Therefore, it is
necessary to develop a more comprehensive and efficient system
to identify the stage-specific gene expression signatures in embry-
onic development and to evaluate the toxicity of environmental
chemicals on neural development.
Toxicity testing using embryonic stem cells (ESCs) has been
developed as an efficient approach to assess the effect of
environmental chemicals on neurodevelopment (Seiler et al.,
2006). We have previously reported a mouse embryonic stem
cell (mESC) neural differentiation protocol and showed that it
could be used as an efficient tool to evaluate the toxic effects of
environmental chemicals on neurodevelopment (Nagano et al.,
2012). Furthermore, we have previously developed a method to
quantitatively and statistically analyze microarray gene expres-
sion data using Bayesian networks with a log-linear functional
relationship between genes (Toyoshiba et al., 2004, 2006). We
proposed that advanced Bayesian network analysis is a necessary
tool to understand the accurate linkage in the possible networks
and the mechanism of the action of developmentally neurotoxic
compounds.
During mammalian fetal development, the most active form
of vitamin A, retinoic acid (RA) can pass through the umbilical
cord to the fetus and induce axon formation and neural system
development. ESCs express high levels of RA receptor (RAR)α in
the undifferentiated stage, while RARβ begins to be expressed after
www.frontiersin.org August 2012 | Volume 3 | Article 141 | 1
Akanuma et al. Advanced Bayesian network analysis
embryoid body (EB) formation (Shiotsugu et al., 2004; Wilson and
Maden, 2005; So et al., 2006). A series of RA concentrations were
examined to detect neural cell identity during neuronal differenti-
ation from mESC (Okada et al., 2004; Engberg et al., 2010). They
reported that the 10−8 M of RA would be an optimum dose to
induce cerebral and mesencephalic neurons and the 10−7 M of RA
had capability to induce motor neurons (Kawasaki et al., 2000;
Nishimura et al., 2003; Miyazaki et al., 2005).
Therefore, in the present study, we focused on identification of
stage-specific gene expressions and analyzed their relationship net-
work during mESC neurodevelopmental period after RA exposure
at 10−8 and 10−7 M, using an advanced Bayesian network analysis.
MATERIALS AND METHODS
CELL CULTURE AND DIFFERENTIATION
B6G-2 mESCs (RIKEN Cell Bank, Tsukuba, Ibaraki, Japan) were
maintained in Dulbecco’s modified Eagle’s medium (Invitro-
gen, Carlsbad, CA, USA) supplemented with 15% knockout
serum replacement (Invitrogen), 100µM non-essential amino
acids (Invitrogen), 100µM 2-mercaptoethanol (Invitrogen), and
1000 U/ml leukemia inhibitory factor (LIF; Invitrogen) in gela-
tinized tissue culture dishes. On the first day of differentiation
(DoD 0), cells were transferred in to 24 well plate in media with-
out LIF and allowed to form EBs. The media was changed by every
2 days. RA was added during DoD 2–6 to induce neuronal differ-
entiation. On DoD 8, EBs were transferred to l-ornithine/laminin-
coated 24 well plates (BD Bio Coat, BD, Franklin Lakes, NJ, USA)
and were cultured with neural medium from DoD 22 to DoD 36
to promote further neural differentiation (Figure 1A).
IMMUNOCYTOCHEMISTRY AND MORPHOLOGICAL ANALYSIS
On DoD 8 and DoD 36, EBs, and their derivatives were fixed
with 4% PFA in PBS for 15 min and then performed immunos-
taining with the conventional methods. Cells were incubated with
primary antibodies overnight at 4˚C at the following dilutions:
anti-microtubule-associated protein 2 (Map2) antibody (Sigma-
Aldrich, Poole, UK; 1:200) and mouse anti-glial fibrillary acidic
protein (Gfap) monoclonal antibody (Chemicon International,
A
B
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FIGURE 1 | Experimental protocols and morphological analysis of
the effect of RA on the neural differentiation of mESCs. (A) A
Schematic diagram of cell cultures and chemical exposures. (B)
Pictures of mESCs, EBs, and neurospheres (NS) with neurite growth
derived from neurosphere in fluorescent fields. Green, blue, and red
fluorescent images indicate GFP of cytoskeleton proteins, nuclei
stained with Hoechst and neuronal cells and neurites stained with the
anti Map2 antibody. Scale bar is 100µm. (C) Morphological analysis of
neuronal cell lineages exposed to RAs. Comparison of the EB areas on
DoD 8 and DoD 36 showed that the EB area decreased with neuronal
cell development. In RA-treated EBs, the numbers of Map2-positive
axons and Gfap-positive cells were increased compared with the
control. Symbols of C, R8, and R7 indicate vehicle control, RA 10−8 M,
and RA 10−7 M.
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Temecula, CA, USA; 1:200). Cells were rinsed with PBS and then
incubated with Alexa-conjugated secondary antibodies (1:1000,
Alexa Fluor 546, Invitrogen). Hoechst 33342 solution (Dojindo
Laboratories, Kumamoto, Japan) was used for counter-staining.
Immunofluorescence images were acquired with six biological
replicates per condition using an IN Cell Analyzer 1000 (GE
Healthcare, Buckinghamshire, UK) and analyzed using IN Cell
Developer Tool Box 1.7 (GE Healthcare). All morphological
analysis experiments were performed in triplicate to test the
reproducibility of the results. Statistical analysis was performed
using two-tailed Student’s t -test. Relationships were considered
statistically significant with p< 0.05.
DNA MICROARRAY ANALYSIS
Total RNA was isolated on DoD 0, 2, 8, and 36 with six biological
replicates. And then, single mixed RNA sample per condition was
applied to Illumina MouseWG-6v1.0 expression BeadChips cov-
ering 46,643 transcripts including 26,766 annotated coding tran-
scripts 2, according to the manufacturer’s instructions (Illumina,
San Diego, CA, USA). The arrays were scanned in accordance with
the manufacturer’s directions. Raw expression values of each gene
were normalized with median centered by GeneSpring GX10.02
software (Agilent Technologies, Palo Alto, CA, USA). Normal-
ized data were deposited in the National Center for Biotech-
nology Information Gene Expression Omnibus1 (accession no.
GSE37602).
SELECTION OF GENE SETS
To capture gene expression signatures of stage-specific changes
during neural differentiation of mESCs, we performed three
approaches to determine gene sets for Bayesian network analysis.
Marker genes, which are commonly used to analyze pluripotency
and development of neural cells, were selected as the literature-
based gene set (set 1) by review of the published literature. The
analysis-based gene set (set 2) was selected by the combined use
of the knowledge-based database and the following classification
methods. Candidate genes involved in axon guidance maps, the
nerve growth factor (NGF) pathway, and RA signaling were pre-
liminarily selected from the Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway database2 and then genes with spe-
cific expression patterns were identified using SOM and PCA.
Finally, the enrichment gene set (set 3) was selected by clustering
expression values of candidate genes contained in the Neuroge-
nesis and Neural Stem Cell PCR Array (SABiosciences, Valencia,
CA, USA) using SOM and PCA. SOM and PCA were performed
using GeneSpring GX10.02 software (Agilent Technology). Briefly,
SOM clustering was done by conditions in which similarity mea-
sure: euclidean, maximum number of iterations: 50, numbers of
grid rows and columns were 2× 4. Then each eight clusters of
SOM were analyzed by PCA with four components of eigenval-
ues (component 1 was more than 40% and component 2 was
10%). To develop set 2 and 3, we collected genes with maximum
and minimum values in the PCA component 1 from each SOM
cluster.
1www.ncbi.nlm.nih.gov/geo
2 http://www.genome.jp/kegg/pathway.html
GENE INTERACTION NETWORK ANALYSIS
We used a modified gene interaction network (GIN) based on our
previous studies (Yamanaka et al., 2004; Toyoshiba et al., 2006;
Nagano et al., 2012). The GIN was quantified to calculate the pos-
terior probability distribution for the strength of the linkages based
on gene expression and chemical exposure dose datasets. Briefly,
a GIN consists of a collection of P nodes, denoted G1, G2, . . .,
GP, with observed values n1, n2, . . . np. βij (i, j = 1, 2, . . ., P) are
parameters in the log-linear function form describing the linkage
from node i to node j. Mathematically, this is written as
E
[
log
(
Gj
)] = P∑
i=1, 6=j
Iijβij log (ni)
where E[log(Gj)] represents the expectation for the natural loga-
rithm of Gj, and Iij(i, j = 1, 2, . . ., P) is an indicator function that
equals 1 if node Gi has a link to node Gj, otherwise it equals 0.
If a node has a regulatory effect on node Gi, then that node is
referred to as a “Parent of node Gi,” and we refer to it as belonging
to the set Pa (Gi). The prior distribution for Iij was assumed to be a
Bernoulli distribution with success probability pij when Iij= 1. In
the uninformative case, pij could be set to 0.5 and if there is some
expectation that Iij is not equal to zero, the prior probability could
be set higher. The posterior distributions for the linkages were
derived using Gibbs sampling. The network was used to evaluate
the ability of the algorithm to have a higher posterior probability
(p-value). Transition matrices were generated at p> 0.5.
RESULTS
EFFECTS OF RA ON NEURAL DIFFERENTIATION
Exposure to RA at different concentrations during EB formation
induced neuronal and glial cell lineages from mESCs (Figure 1A).
Morphological analysis with immunofluorescent staining showed
that RA significantly increased the size of neurosphere, neuronal
cells, and glial cells at DoD 36 (Figures 1B,C).
GENE SET SELECTION FOR GENE NETWORK ANALYSIS
To investigate transcriptomic changes as a result of neuronal dif-
ferentiations and influences of RAs, a cDNA microarray was used
to compare expression levels with and without the RA treatments
in EB formations and neurosphere developments by hierarchical
clustering methods (Figure 2A). From 22,188 transcripts pre-
sented from eight microarrays, 1,157 transcripts with expression
differences greater than 2.0-fold in at least 1 microarray were
selected for further analysis. From the microarray analysis, Nanog
as a marker of undifferentiated ESCs and, Nestin, Map2, and Gfap
as markers of neural cells were differentially expressed by RA treat-
ments at differential doses during the neural differentiation of
mESCs, suggesting that our protocol could detect the effects of
RA on neuronal differentiation (Figure 2B). A high level of Nanog
expression on DoD 8 was decreased in a dose-dependent fashion
following RA treatments, but not on DoD 36. Nestin expression
was increased by the 10−7 M RA treatment on DoD 8 and DoD 36.
Map2 and Gfap expressions were also increased by RA treatments
on DoD 8 and DoD 36 (Figure 2B).
Three gene sets were selected for the Bayesian network analysis
by our strategies as shown in Figure 2C. Selected gene sets are
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FIGURE 2 | Gene expression analysis by DNA microarray and gene
selection strategies for the Bayesian network analysis of
differentiation of neuronal cells derived from mESCs. (A) Heat map of
hierarchical clustering generated from DNA microarray data. Color-coding
in the heat map is that blue from red indicates – 4.0 from 4.0 log2
normalized intensity value by ES values, indicating that red is for up
regulation and blue is for down regulation. (B) Gene expression of
pluripotency and differentiation markers in mESCs, EB, and NS measured
in DNA microarray. Symbols of C, R8, and R7 indicate vehicle control, RA
10−8 M, and RA 10−7 M. (C) Stage-specific gene expression signatures in
response to RA during the neural differentiation of mESCs were identified
as follows: set 1 was a set of genes selected from the literature; set 2 was
selected by SOM and PCA after selecting 36 genes from pathway maps;
set 3 was selected by SOM and PCA after selecting 159 genes from
pathway maps. Expression values of microarray data corresponding to
genes in these three sets were used for the Bayesian network analysis.
listed in Table 1. Concretely, set 1 was selected by the review of
published articles and included Nanog (Mitsui et al., 2003; Loh
et al., 2006), Pou5f1 (Okazawa et al., 1991; Catena et al., 2004;
Akamatsu et al., 2009), Zfl42 (Shi et al., 2006; Scotland et al.,
2009), Fgfr1 (Jukkola et al., 2006; Yang et al., 2008; Lee et al.,
2009), Sox2 (Tomioka et al., 2002; Graham et al., 2003; Tanaka
et al., 2004; Jin et al., 2009), and Oligo2 (Ahn et al., 2008). RARs
were also added to set 1 to assess the effects of RA. Set 2 was
selected by the combined use of the KEGG database and SOM and
PCA classification methods. Firstly, a list of 36 candidate genes
was compiled according to axon guidance, NGF pathway, and RA
signaling of KEGG database. It is known that NGF can induce
neuronal differentiation of mESCs (Schuldiner et al., 2001) while
RA can induce the expression of the NGF receptor (p75) dur-
ing the neuronal differentiation of PC12 cells (Cosgaya et al.,
1996). Therefore, genes in the NGF pathway were selected as indi-
cators to assess the effects of RA on the neural differentiation
of mESCs. The 36 candidate genes were then classified in to 17
classes by SOM, and representative genes were selected from each
class by PCA. Finally, 16 genes were selected for set 3 by SOM
and PCA clustering from 159 candidate genes contained in the
Neurogenesis and Neural Stem Cell PCR Array (SABiosciences).
Furthermore, specific markers for astrocytes (Gfap), mature neu-
rons (Map2), neuronal stem cells (Nestin), and young neurons
(Tuj1) were added to sets 2 and 3 to assess the stage of neuronal
differentiation.
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Table 1 | Lists of gene sets for identifying gene networks.
Category Set1 Set2 Set3
Pathway signaling Map2k1 Adora2a
Mapk1 Drd5
Mapk3 Fgf13
Pla2g6 Gnao1
Rps6ka1 Notch2
Shc1 Tnr
Transcription/chromatin regulation RARa Atbf1 Ascl1
RARb Cdyl Gusb
RARg Rhog Mef2c
Nanog Rif1 Pax5
Pou5f1 Sall1 Pou3f3
Zfp42 Smarcad1
Neural development Fgfr1 Fos Bdnf
Olig2 Gbx2 Gdnf
Sox2 Hras1 Nrp2
Raf1 Slit2
Sox2 Ywhah
Neural marker Gfap Gfap Gfap
Map2 Map2 Map2
Nestin Nestin Nestin
Tuj1 Tuji1 Tuji1
GENE INTERACTION ANALYSIS
Matrices transferred from gene interaction analysis for set 1, set 2,
and set 3 are shown in Figures 3–5, respectively (see Figures A1–
A3 in Appendix as references and Tables S1–S6 in Supplementary
Material for input data and output raw-results). In the control
group of set 1, Nanog, and Sox2 (Figure 3) which control ESC
pluripotency, regulate many other genes on DoD 0, 2, and 8. On
DoD 36, Sox2 does not regulate any gene. In RA-treated groups
of set 1, linkages of RARs in the matrix indicated that these genes
might play principal roles in the regulation of expression of other
genes. Briefly, the effect of RA was observed on DoD 8, in which
RA 10−8 or 10−7 M aggravated Nanog and Pou5f1. On DoD 36, the
matrix was more strongly influenced by RA, in which the neural
marker genes such as Gfap and Map2 up-regulated the other genes,
indicating that RA enhances neural differentiation (Figure 3).
Gene interaction matrix analysis for set 2 is shown in Figure 4.
In the mESC matrix, linkages between genes were concentrated to
categories of pathway signaling and neural development, which is
similar with those in set 1 on DoD 8 and DoD 36. It is note-
worthy that Gbx2 as a neuronal development marker strongly
up-regulated Mapk3, Atbf1, Rhog, Sall1, Smarcad, Sox2, and Map2
on DoD 8 as well as DoD 36 in RA 10−8 M matrices. RA-treated
matrices showed that linkages shifted to the right side of the matrix
with increasing RA concentrations. Finally, linkages on DoD 36
were concentrated to categories of neural development and neural
markers.
Gene interaction network analysis for set 3 is shown in Figure 5.
In the mESC matrix, linkages between genes were concentrated to
transcription/chromatin regulation and pathway signaling cate-
gories. Linkages between genes in the control matrix on DoD 8
were concentrated to pathway signaling and neural development
categories. In the RA-treated matrices, linkages between genes
moved to the neural marker category from the neural develop-
ment category in a dose-dependent manner. Most of the link-
ages between genes in the RA-treated matrices on DoD 36 were
concentrated to pathway signaling and neural marker categories,
suggesting that Gfap mainly regulates neuronal differentiation.
DISCUSSION
In the present study, a prediction model for the neural differentia-
tion of mESCs was established and stage-specific gene expression
signatures in response to RA were identified using Bayesian net-
work analysis. Our present findings showed that RA significantly
increased the size of neurosphere, neuronal cells, and glial cells on
DoD 36. In addition, neural marker Gfap remarkably up-regulated
the other genes in gene set 1 and 3, and neural development marker
Gbx2 significantly up-regulated the other genes in gene set 2 on
DoD 36 in the presence of RA. These findings suggest that our
protocol for identification of developmental stage-specific gene
expression and interaction is a useful method for the screening
of environmental chemical toxicity during neurodevelopmental
periods.
RA is known as a severe teratogen and causes central nervous
system malformations. However, in vivo study indicated that high
dose (70 mg/kg body weight; b.w.) of RA could induce teratogenic
effects during gestational day 7–9 in Swiss mice (Veiga Quemelo
et al., 2007). In addition, it was reported that the physiological
dose that cannot affect RAR level was 1 mg/kg b.w. and minimally
teratogenic dose was 10 mg/kg b.w. and completely teratogenic
dose was 100 mg/kg b.w. in gestational day 9 of mouse (Harnisha
et al., 1990). In the present study, we selected the dose of RA as
10−8 and 10−7 M because endogenous levels of RA-induced neural
differentiation in the early embryo are approximately 1–10 nM
(Maden et al., 1998; Mic et al., 2003). Therefore, we considered
to use 10−8 M as a low dose and 10−7 M as a high dose to exam-
ine the effect of RA on stage-specific gene expression signature in
mESCs.
We have also successfully designed a mESC neural differentia-
tion protocol to evaluate the effect of RA on the neural differentia-
tion of mESCs. Morphological analysis using a high-content image
analyzer was able to acquire varying differences of differentiation
from mESCs to neural cells by the RA treatment. For instance,
neuronal or glial differentiation from neuronal ESCs was delayed
in control cells without induction by RA, which was further con-
firmed by the lower expression levels of Map2 and Gfap detected
on DoD 36. RA treatments promoted the loss of pluripotency and
differentiation into neural ESCs up to DoD 36 in the present study
(Figures 1B,C), suggesting that the maturation of Map2-positive
neurons and Gfap-positive astrocytes were accelerated by RA treat-
ment. Our results are consistent with a study showing that RA and
LIF enhance the induction of Gfap-positive astrocytes from mice
neural progenitor cells via epigenetic modifications (Asano et al.,
2009).
In restricted sample size analysis like the present study, sim-
ulations using Bayesian network analysis have been suggested
to be a very effective method (Toyoshiba et al., 2006). Our
present study provided a new experimental evidence that Bayesian
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FIGURE 3 | Matrices in gene interaction networks of the
literature-based gene set (set 1) in mESCs, EB, and NP of neuronal
differentiation. Gene Symbols, RARa, RARb, RARg, Nanog, Pou5f1,
Zfp42, Fgfr1, Olig2, Sox2, Gfap, Map2, Nestin,Tuj1, line up in order of
up to down in the y axis and left to right in the x axis. Red indicates
upregulated genes and blue indicates downregulated genes. Red
indicates that genes from the y axis upregulated genes from the x
axis. Blue indicates that genes from the y axis downregulated genes
from the x axis. Symbols of C, R8, and R7 indicate vehicle control, RA
10−8 M, and RA 10−7 M.
network analysis was effective to identify the functions of the
well-known neural development regulators, such as Gfap and
SOX2 (Figures 3–5), in response to RA during the neural dif-
ferentiation of mESCs and suggested its further application to
predict developmental neurotoxicity of environmental chemicals.
However, in the simulation analysis, one major problem is to select
genetic markers related with a trait of interest. To perform accurate
simulation, it is undesirable to select genes with similar expression
patterns. Similar variables could significantly affect the analysis
results and potentially lead to biased results. Hence, the selection of
genes with distinct expression patterns, which can represent each
stage of mESC neural differentiation, seems to be important in the
outcome of the GIN analysis. In this study, we selected gene sets for
GIN analysis by the combined use of two classification methods,
SOM and PCA. SOM is a powerful data mining method, whose
algorithm is an unsupervised competitive learning neural network
and it maps high-dimensional data into a simple low-dimensional
display (Kohonen, 1990; Zhang et al., 2008). Therefore, SOM is
able to classify the temporal expression data for each gene. After
classification by SOM based on gene expression patterns, the rep-
resentative genes were further selected from each class by PCA.
PCA is a standard technique of pattern recognition and has been
widely used as a tool in exploratory data analysis and for making
predictive models in many biological systems (Aiba et al., 2006; van
Dartel et al., 2010; Qin et al., 2011). In this study, the genes selected
by SOM and PCA were shown to have adequate simulation para-
meters to evaluate the effects of RA on the neural differentiation
of mESCs.
Finally, our prediction model, employing Bayesian network
analysis, showed that it is possible to capture genetic correlations
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FIGURE 4 | Matrices in gene interaction networks of the analysis-based
gene set (set 2) in mESCs, EB, and NP of neuronal differentiation. Gene
Symbols, Map2k1, Mapk1, Mapk3, Pla2g6, Rps6ka1, Shc1, Atbf1, Cdv1,
Rhog, Rif1, Sall1, Smarcad1, Fos, Gbx2, Hras1, Raf1, Sox2, Gfap, Map2,
Nestin,Tuji1 line up in order of up to down in the y axis and left to right in the
x axis. Red indicates upregulated genes and blue indicates down regulated
genes. Red indicates that genes from the y axis up regulated genes from the
x axis. Blue indicates that genes from the y axis downregulated genes from
the x axis. Symbols of C, R8, and R7 indicate vehicle control, RA 10−8 M, and
RA 10−7 M.
between genes and to identify slight variations for different
conditions. We performed the same prediction model for three
gene sets of different genetic constitution. Our study indicated
that the GIN was able to capture features of each developmental
stage during the neural differentiation of mESCs. RA treatment
could change the network structure in a dose-dependent man-
ner. In addition, among the three gene sets, set 3 was the best
according to the morphological results. We found that the Gfap
gene was linked with other genes in the RA 10−7 M matrix in
the GIN analysis, while the number of Gfap-positive cells was
markedly increased by RA 10−7 M treatment on DoD 36 in the
morphological analysis. This suggested that the approach used in
this study, of the independent selection of gene sets using SOM or
PCA, was efficient. This Bayesian model might also be useful to
investigate the developmental toxicity of environmental chemicals
other than RA.
In summary, to find the optimized GIN that integrated chemi-
cal effects, we created three different gene sets and then performed
GIN analysis using Bayesian network algorithms to capture the
stage-specific gene expression signatures in response to RA treat-
ment during the neural differentiation of mESCs. “Toxicity Testing
in the Twenty First Century – A vision and a strategy” issued
by the US Nuclear Regulatory Commission indicated that the
most important issue for toxicity testing is how to connect the
extensive body of toxicity information to high-throughput screen-
ing to perform chemical risk assessment (Thomas et al., 2007;
Davis et al., 2008; Ellinger-Ziegelbauer et al., 2009; Hubal, 2009).
Here, we described a novel approach to identify stage-specific
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FIGURE 5 | Matrices in gene interaction networks of the enrichment
gene set (set 3) in mESCs, EB, and NP of neuronal differentiation. Gene
Symbols, Adora2a, Drd5, Fgf13, Gnao1, Notch2,Tnr, Ascl1, Gusb, Mef2c,
Pax5, Pou3f3, Bdnf, Gdnf, Nrp2, Slit2,Ywhah, Gfap, Map2, Nestin,Tuji1 line
up in order of up to down in the y axis and left to right in the x axis. Red
indicates up regulated genes and blue indicates down regulated genes. Red
indicates that genes from the y axis up regulated genes from the x axis.
Blue indicates that genes from the y axis down regulated genes from the x
axis. Symbols of C, R8, and R7 indicate vehicle control, RA 10−8 M, and RA
10−7 M.
gene expression in embryonic development and suggested its
application to evaluate the neural developmental toxicity of
environmental chemicals in future studies.
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SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online at:
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Table S1 | Input data of gene expression values for set 1. Values are
normalized expression values in beads of each gene with approximate 30
replicates.
Table S2 | Input data of gene expression values for set 2. Values are
normalized expression values in beads of each gene with approximate 30
replicates.
Table S3 | Input data of gene expression values for set 3. Values are
normalized expression values in beads of each gene with approximate 30
replicates.
Table S4 | Output results of the Bayesian network analysis with gene
expression values for set 1. Values are posterior probabilities.
Table S5 | Output results of the Bayesian network analysis with gene
expression values for set 2. Values are posterior probabilities.
Table S6 | Output results of the Bayesian network analysis with gene
expression values for set 3. Values are posterior probabilities.
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